Viewing Study NCT03544060


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-27 @ 11:22 PM
Study NCT ID: NCT03544060
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-09-16
First Post: 2018-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)
Sponsor: Akcea Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ISIS 304801
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View